BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10433467)

  • 1. Surgical management after doxorubicin and epirubicin extravasation.
    Fleming A; Butler B; Gault D
    J Hand Surg Br; 1999 Jun; 24(3):390. PubMed ID: 10433467
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgical management after doxorubicin and epirubicin extravasation.
    Heitmann C; Durmus C; Ingianni G
    J Hand Surg Br; 1998 Oct; 23(5):666-8. PubMed ID: 9821616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin extravasation: consequences of delayed management.
    Hale O; Deutsch PG; Lahiri A
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28062432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recall phenomenon following epirubicin.
    Wilson J; Carder P; Gooi J; Nishikawa H
    Clin Oncol (R Coll Radiol); 1999; 11(6):424-5. PubMed ID: 10663338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Images in clinical medicine. Extravasation of epirubicin.
    Vano-Galvan S; Jaen P
    N Engl J Med; 2009 May; 360(20):2117. PubMed ID: 19439746
    [No Abstract]   [Full Text] [Related]  

  • 6. Port-a-Cath extravasation of vesicant cytotoxics: surgical options for a rare complication of cancer chemotherapy.
    Haslik W; Hacker S; Felberbauer FX; Thallinger C; Bartsch R; Kornauth C; Deutschmann C; Mader RM
    Eur J Surg Oncol; 2015 Mar; 41(3):378-85. PubMed ID: 25515823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early surgical suction and washout for treatment of cytotoxic drug extravasations.
    Vandeweyer E; Deraemaecker R
    Acta Chir Belg; 2000 Feb; 100(1):37-8. PubMed ID: 10776527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue distribution of epirubicin after severe extravasation in humans.
    Nedomansky J; Haslik W; Pluschnig U; Kornauth C; Deutschmann C; Hacker S; Steger GG; Bartsch R; Mader RM
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):203-209. PubMed ID: 33907881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional cell bladder tumours.
    Rosen M
    Br J Urol; 1997 Dec; 80(6):966. PubMed ID: 9439427
    [No Abstract]   [Full Text] [Related]  

  • 10. Images in emergency medicine. Swollen hand. Anthracycline chemotherapy extravasation.
    Schulmeister L; Pollack CV
    Ann Emerg Med; 2011 Apr; 57(4):417, 422. PubMed ID: 21453822
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness of magnetic resonance imaging for surgical management of extravasation of an antitumor agent: a case report.
    Yama N; Tsuchida Y; Nuka S; Kitagawa S; Saito J; Hyodoh H; Hyodoh K; Koito K; Tamakawa M; Akiba H; Hareyama M; Asai Y
    Jpn J Clin Oncol; 2001 Mar; 31(3):122-4. PubMed ID: 11336325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extravasation in intravenous chemotherapy].
    Harwood K; Herrmann R
    Dtsch Med Wochenschr; 1994 Mar; 119(10):359-60. PubMed ID: 8125043
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorescence microscopic demonstration and demarcation of doxorubicin extravasation. Experimental and clinical studies.
    Dahlstrøm KK; Chenoufi HL; Daugaard S
    Cancer; 1990 Apr; 65(8):1722-6. PubMed ID: 2317755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful management of doxorubicin overdose and extravasation in a dog with lymphoma.
    Kicenuik KS; Northrup NC; Clarke DM; Bazzle LJ
    Can Vet J; 2018 Oct; 59(10):1079-1084. PubMed ID: 30510312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of epirubicin and doxorubicin cardiotoxicity in children and adolescents treated within the German Cooperative Soft Tissue Sarcoma Study (CWS).
    Stöhr W; Paulides M; Brecht I; Kremers A; Treuner J; Langer T; Beck JD;
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):35-40. PubMed ID: 16205946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The wash-out technique in the management of delayed presentations of extravasation injuries.
    Dionyssiou D; Chantes A; Gravvanis A; Demiri E
    J Hand Surg Eur Vol; 2011 Jan; 36(1):66-9. PubMed ID: 20682583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous recall phenomenon at the site of previous doxorubicin extravasation after second-line chemotherapy.
    Valencak J; Troch M; Raderer M
    J Natl Cancer Inst; 2007 Jan; 99(2):177-8. PubMed ID: 17228004
    [No Abstract]   [Full Text] [Related]  

  • 18. Accidental anthracycline extravasation.
    Held-Warmkessel J
    Nursing; 2007 Dec; 37(12 Pt.1):72. PubMed ID: 18090648
    [No Abstract]   [Full Text] [Related]  

  • 19. BET 3: emergency management of anthracycline extravasation.
    Drake D
    Emerg Med J; 2012 Sep; 29(9):777-9. PubMed ID: 22903427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study.
    Lotrionte M; Palazzoni G; Abbate A; De Marco E; Mezzaroma E; Di Persio S; Frati G; Loperfido F; Biondi-Zoccai G
    Int J Cardiol; 2013 Aug; 167(3):1055-7. PubMed ID: 23174173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.